Andrzej Friedman
Overview
Explore the profile of Andrzej Friedman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1099
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Figura M, Mrozowicz A, Milanowski L, Szlufik S, Rackowska E, Lypkan H, et al.
J Parkinsons Dis
. 2024 Jun;
14(5):1039-1049.
PMID: 38905055
Background: Levodopa is the gold standard of treatment in Parkinson's disease (PD). Its clinical effect changes as the disease progresses. Wearing off is a frequent first manifestation of motor fluctuations....
2.
Figura M, Przytycka J, Dzierzecki S, Szumilas M, Szlufik S, Milanowski L, et al.
Neurol Neurochir Pol
. 2024 May;
58(3):283-291.
PMID: 38742610
Introduction: Unilateral gamma knife thalamotomy (GKT) is a treatment option for pharmacoresistant tremor of various aetiologies. There have been to date no randomised controlled trials performed to assess its safety...
3.
Alster P, Otto-Slusarczyk D, Szlufik S, Duszynska-Was K, Drzewinska A, Wiercinska-Drapalo A, et al.
Sci Rep
. 2024 Feb;
14(1):2805.
PMID: 38307947
Progressive Supranuclear Palsy (PSP) is an atypical parkinsonism. Major subtypes of the disease: PSP-Richardson's Syndrome (PSP-RS) and PSP Parkinsonism Predominant (PSP-P) vary in clinical features, the pathomechanism remains unexplored. The...
4.
Madetko-Alster N, Otto-Slusarczyk D, Wiercinska-Drapalo A, Koziorowski D, Szlufik S, Samborska-Cwik J, et al.
Int J Mol Sci
. 2023 Oct;
24(20).
PMID: 37894815
Progressive supranuclear palsy (PSP) is an atypical parkinsonian syndrome based on tau pathology; its clinical phenotype differs, but PSP with Richardson's syndrome (PSP-RS) and the PSP parkinsonism predominant (PSP-P) variant...
5.
Alster P, Madetko-Alster N, Otto-Slusarczyk D, Migda A, Migda B, Struga M, et al.
Neurol Neurochir Pol
. 2023 Jul;
57(4):335-343.
PMID: 37461841
Introduction: The pathogenesis of parkinsonisms is not fully understood. Among possible factors which may influence the course of neurodegenerative diseases, endocrine abnormalities may be interpreted as having been underevaluated. State...
6.
Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS)
Alster P, Madetko-Alster N, Migda A, Migda B, Kutylowski M, Krolicki L, et al.
Neurol Neurochir Pol
. 2023 Mar;
57(3):229-234.
PMID: 36928793
Introduction: Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are clinical manifestations of tauopathies. They are commonly associated with rapid motor and cognitive deterioration. Sleep disturbances are less frequently described...
7.
Madetko-Alster N, Alster P, Bartosova T, Klempir J, Migda B, Przewodowska D, et al.
Neurol Neurochir Pol
. 2022 Dec;
57(2):177-182.
PMID: 36519660
Introduction: Corticobasal syndrome (CBS) is a specific clinical manifestation shared by multiple pathologies. The exact mechanism of this phenomenon remains unclear. Differential diagnosis of CBS in everyday clinical practice is...
8.
Nowak J, Kopczynski M, Friedman A, Koziorowski D, Figura M
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140158
Numerous studies have highlighted the role of the gastrointestinal system in Parkinson disease pathogenesis. It is likely triggered by proinflammatory markers produced by specific gut bacteria. This review's aim is...
9.
Alster P, Madetko N, Migda B, Nieciecki M, Kutylowski M, Krolicki L, et al.
Diagnostics (Basel)
. 2022 Jul;
12(7).
PMID: 35885575
Progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS) are clinical manifestations of tauopathic Parkinsonian syndromes. Due to their overlapping symptomatology, the differential diagnosis of these entities may be difficult...
10.
Alster P, Nieciecki M, Migda B, Kutylowski M, Madetko N, Duszynska-Was K, et al.
Diagnostics (Basel)
. 2022 Feb;
12(2).
PMID: 35204476
Multiple System Atrophy-Parkinsonism Predominant (MSA-P) and Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P) are the clinical manifestations of atypical parkinsonism. Currently, there are no efficient in vivo methods available relating to neuroimaging...